Osteonecrosis of the jaw related to bevacizumab

被引：155

作者：

Estilo, Cherry L. ^{[1
]}

Fornier, Monica ^{[1
]}

Farooki, Azeez ^{[1
]}

Carlson, Diane ^{[1
]}

Bohle, George, III ^{[1
]}

Huryn, Joseph M. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 24期

关键词：

D O I：

10.1200/JCO.2007.15.5424

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

[No abstract available]

引用

收藏

页码：4037 / 4038

页数：2

相关论文

共 11 条

[1]

Cancer interaction with the bone microenvironment - A workshop of the National Institutes of Health Tumor Microenvironment Study Section [J].

Cher, ML ;

Towler, DA ;

Rafii, S ;

Rowley, D ;

Donahue, HJ ;

Keller, E ;

Herlyn, M ;

Cho, EA ;

Chung, LWK .

AMERICAN JOURNAL OF PATHOLOGY, 2006, 168 (05) :1405-1412

[2]

Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy [J].

Dvorak, HF .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (21) :4368-4380

[3]

Bevacizumab-induced nasal septum perforation [J].

Fakih, Marwan G. ;

Lombardo, Jeffrey C. .

ONCOLOGIST, 2006, 11 (01) :85-86

[4]

Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non-small-cell lung cancer [J].

Herbst, Roy S. ;

O'Neill, Vincent J. ;

Fehrenbacher, Louis ;

Belani, Chandra P. ;

Bonomi, Philip D. ;

Hart, Lowell ;

Melnyk, Ostap ;

Ramies, David ;

Lin, Ming ;

Sandler, Alan .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) :4743-4750

[5]

Clinical translation of angiogenesis inhibitors [J].

Kerbel, R ;

Folkman, J .

NATURE REVIEWS CANCER, 2002, 2 (10) :727-739

[6]

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer [J].

Miller, KD ;

Chap, LI ;

Holmes, FA ;

Cobleigh, MA ;

Marcom, PK ;

Fehrenbacher, L ;

Dickler, M ;

Overmoyer, BA ;

Reimann, JD ;

Sing, AP ;

Langmuir, V ;

Rugo, HS .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) :792-799

[7]

Gastrointestinal perforation due to bevacizumab in colorectal cancer [J].

Saif, Muhammad Wasif ;

Elfiky, Aymen ;

Salem, Ronald R. .

ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (06) :1860-1869

[8]

Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies [J].

Shih, Ted ;

Lindley, Celeste .

CLINICAL THERAPEUTICS, 2006, 28 (11) :1779-1802

[9]

Nasal septum perforation in a bevacizumab-treated patient with metastatic breast cancer [J].

Traina, Tiffany A. ;

Norton, Larry ;

Drucker, Karen ;

Singh, Buvanesh .

ONCOLOGIST, 2006, 11 (10) :1070-1071

[10]

Van Poznak C, 2006, ONCOLOGY-NY, V20, P1053